Metabolic dysfunction-associated steatotic liver disease (MASLD) is now the most common chronic liver disease in the Western world, driven by obesity, insulin resistance, and systemic inflammation.

Startup is using Bitcoin and the Lightning Network to enable flexible, usage-based monetization of digital apps, widgets, tools, online content, and other experiences based on quality and value ...

Akero Therapeutics (AKRO) has been firing on all cylinders with respect to the development of its FGF21 drug efruxifermin which is being developed to treat patients with compensated cirrhosis [F4] due ...

In my last note on Altimmune, Inc. (ALT) shared in late August, I made the bull case for its stock. I discussed the Gaithersburg, Maryland based biotech's lead and only drug candidate, pemvidutide, ...

Metabolic dysfunction-associated steatohepatitis (MASH) starts in your liver, but it can have body-wide effects. These effects increase your risk of conditions like heart disease, chronic kidney ...

NEW YORK, NEW YORK - JUNE 21: Dan Marino speaks onstage at Fanatics Fest NYC 2025 at Javits Center on June 21, 2025 in New York City. (Photo by Slaven Vlasic/Getty Images) To say that Dan Marino has ...